MX7197E - Procedimiento para elaborar una vacuna combinada de un polisacarido capsular de h.influenzae tipo b y antigenos de b.pertussis - Google Patents

Procedimiento para elaborar una vacuna combinada de un polisacarido capsular de h.influenzae tipo b y antigenos de b.pertussis

Info

Publication number
MX7197E
MX7197E MX8210336U MX1033682U MX7197E MX 7197 E MX7197 E MX 7197E MX 8210336 U MX8210336 U MX 8210336U MX 1033682 U MX1033682 U MX 1033682U MX 7197 E MX7197 E MX 7197E
Authority
MX
Mexico
Prior art keywords
preparing
procedure
capsular polysaccharide
influenzae type
combined vaccine
Prior art date
Application number
MX8210336U
Other languages
English (en)
Inventor
Joseph S C Kuo
Nobuo Monji
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of MX7197E publication Critical patent/MX7197E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX8210336U 1981-11-19 1982-10-22 Procedimiento para elaborar una vacuna combinada de un polisacarido capsular de h.influenzae tipo b y antigenos de b.pertussis MX7197E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/323,523 US4474758A (en) 1981-11-19 1981-11-19 Haemophilus influenzae type b and pertussis outer membrane component combined vaccine

Publications (1)

Publication Number Publication Date
MX7197E true MX7197E (es) 1987-12-23

Family

ID=23259565

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8210336U MX7197E (es) 1981-11-19 1982-10-22 Procedimiento para elaborar una vacuna combinada de un polisacarido capsular de h.influenzae tipo b y antigenos de b.pertussis

Country Status (13)

Country Link
US (1) US4474758A (es)
EP (1) EP0080021B1 (es)
JP (1) JPS5892618A (es)
AR (1) AR229929A1 (es)
AU (1) AU554028B2 (es)
CA (1) CA1192840A (es)
DE (1) DE3269381D1 (es)
DK (1) DK514882A (es)
ES (1) ES8401722A1 (es)
MX (1) MX7197E (es)
NZ (1) NZ202483A (es)
PH (1) PH18773A (es)
ZA (1) ZA828517B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5300632A (en) * 1986-11-18 1994-04-05 Research Foundation Of State University Of New York Method for purifying an outer membrane protein of Haemophilus influenzae
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5019502A (en) * 1989-06-12 1991-05-28 Merck & Company, Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5039610A (en) * 1989-06-12 1991-08-13 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5045456A (en) * 1989-06-12 1991-09-03 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
EP0471177B1 (en) * 1990-08-13 1995-10-04 American Cyanamid Company Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
EP0471954A3 (en) * 1990-08-13 1993-03-03 American Cyanamid Company Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide
US7704959B2 (en) 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
IL24946A (en) * 1965-01-19 1969-05-28 Merck & Co Inc Process for preparing antibodies in cilus pertussis
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4196192A (en) * 1977-10-28 1980-04-01 American Cyanamid Company Combined Haemophilus influenzae type b and pertussis vaccine

Also Published As

Publication number Publication date
ES517524A0 (es) 1984-01-01
PH18773A (en) 1985-09-25
AU554028B2 (en) 1986-08-07
DE3269381D1 (en) 1986-04-03
US4474758A (en) 1984-10-02
CA1192840A (en) 1985-09-03
EP0080021B1 (en) 1986-02-26
EP0080021A3 (en) 1983-11-16
EP0080021A2 (en) 1983-06-01
ES8401722A1 (es) 1984-01-01
AU9071482A (en) 1983-05-26
DK514882A (da) 1983-05-20
NZ202483A (en) 1986-03-14
AR229929A1 (es) 1984-01-31
ZA828517B (en) 1983-09-28
JPS5892618A (ja) 1983-06-02

Similar Documents

Publication Publication Date Title
IL68749A (en) Modified antigens,their preparation and vaccines containing them
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
ES533263A0 (es) Procedimiento para la preparacion de una vacuna neumococcica multivalente.
AR228430A1 (es) Metodo para preparar una vacuna neumococcica multivalente de polisacaridos capsulares purificados
ES496358A0 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
IT1226861B (it) Vaccini contenenti antigeni tumorali e coadiuvanti e relativo procedimento di preparazione
ES529961A0 (es) Procedimiento para preparar vacunas polivalentes adsorbidas y liofilizadas
ES535745A0 (es) Un metodo de producir una vacuna para la hepatitis
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
MX7197E (es) Procedimiento para elaborar una vacuna combinada de un polisacarido capsular de h.influenzae tipo b y antigenos de b.pertussis
IL65835A (en) Protozoal antigen,its preparation and vaccine containing it
DE3276151D1 (en) Oral vaccine for immunization against enteric disease
ES521411A0 (es) Un procedimiento para la preparacion de una vacuna contra picornavirus.
IL65496A0 (en) Protozoal antigen,its preparation and vaccine containing it
MX7528E (es) Procedimiento para la preparacion de una vacuna sintetica
IL62913A (en) Isolation of glycoproteic antigens of a virus and the preparation of a vaccine from such antigens
ES516300A0 (es) Un procedimiento para preparar una composicion tintorea para cabellos humanos.
IL51864A (en) Rabies vaccine and its preparation
DK282384D0 (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
EP0467972A4 (en) Rickettsial antigens for vaccination and diagnosis
GB2062461B (en) Vaccine against newcastle fowl disease
IT7927954A0 (it) Procedimento e stampo per lapreparazione di un semi-elemento di una articolazione omocinetica.
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
GB2144129B (en) Antigens as immunostimulant adjuvants
ZA776822B (en) Vaccine and method for immunotherapy of neoplastic disease